Monoclonal and oligoclonal gammopathy after bone marrow transplantation

• Published in: Blood Vol. 74; no. 8; pp. 2764 - 2768
• Main Authors: Mitus, AJ, Stein, R, Rappeport, JM, Antin, JH, Weinstein, HJ, Alper, CA, Smith, BR
• Format: Journal Article
• Language: English
• Published: 01.12.1989
• DOI: 10.1182/blood.V74.8.2764.bloodjournal7482764
• ISSN: 0006-4971

Serial serum protein electrophoreses were performed on 60 patients undergoing allogeneic and syngeneic bone marrow transplantation (BMT). More than 50% of patients (31 of 60) developed transient oligoclonal and monoclonal gammopathies that appeared an average of 84 days posttransplantation (range 27 to 336 days) and persisted an average of 175 days (range 14 to 652 days). Immunofixation analysis revealed 82% of the M components to be of the immunoglobulin G (IgG) type and 18% to be IgM; 56% were kappa and 44% were lambda. A strong correlation between development of graft versus host disease (GVHD) and appearance of M components was observed (73% incidence in GVHD patients v 27% in non-GVHD patients, P = .0003). Two of the three syngeneic graft recipients also developed monoclonal gammopathies. Evidence of oligoclonal circulating B-cell populations was found in 68% of patients posttransplantation by flow cytometric B-cell clonal excess assay. No correlation of recovery of particular B- or T-lymphocyte subsets and development of M components was seen. The development of transient oligoclonal and monoclonal gammopathies after transplantation may be a ubiquitous finding reflecting recapitulation of early B-cell ontogeny.